Life Healthcare

LHC · JSE · Healthcare / Medical Care Facilities

1,244.00ZAC-1.00 (-0.08%)

Price History

Full chart

Market Stats

Previous Close1,245.00

Open1,255.00

Day Range1,230.00 – 1,255.00

52-Week Range999.78 – 1,302.00

Volume2.44M

Market Cap16.64B

P/E (TTM)12.51

Forward P/E16.98

EPS0.93

Dividend Yield4.99%

Beta0.08

50-Day Avg1,161.24

200-Day Avg1,137.01

About

Life Healthcare Group Holdings Limited, an investment holding company, operates as a private healthcare company in Southern Africa. It operates through Southern Africa " Hospitals Services, Southern Africa - Complementary Services, Southern Africa - Healthcare Services, and International segments. The company operates acute hospitals; and Life Nkanyisa care centres that provide long-term chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, primary healthcare, and substance abuse recovery programme services to patients in the public sector. It also offers mental health, acute rehabilitation, renal dialysis, oncology, and diagnostics services; and training for pharmacists, pharmacists' assistants, and nurses. In addition, the company provides nursing and pharmacy services; and health and well-being, occupational health, emergency medical, and complementary and advisory services. Further, it retains the right to manufacture, commercialise, and distribute Life Molecular Imaging (LMI) products, such as early-stage novel radiotherapeutic and radio diagnostic products in Africa. The company was formerly known as Afrox Healthcare Limited and changed its name to Life Healthcare Group Holdings Limited in January 2005. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEOMr. Peter Gerard Wharton-Hood AMP Harvard, BCom (Hons), CA(SA)
Employees0
HeadquartersOxford Parks, Johannesburg, South Africa, 2196, South Africa
Websitehttps://www.lifehealthcare.co.za

Leadership

Mr. Peter Gerard Wharton-Hood AMP Harvard, BCom (Hons), CA(SA)CEO & Executive Director · b. 1966
Mr. Pieter Phillippus van der Westhuizen CA(SA)CFO & Executive Director · b. 1971
Mr. Craig Ian KoekemoerChief Operations Officer
Mr. David Price B.Sc., M.B.A.Chief Information Officer
Ms. Avanthi ParboosingChief People Officer · b. 1976
Ms. Merle VictorChief Nurse Officer
Dr. Karisha QuarrieChief Medical Officer
Mr. Brett MillChief Actuary & Risk Officer
Ms. Joshila Ranchhod B.A., L.L.B.Group Company Secretary
Mr. Guy E. BlomfieldNon-Executive Director of Life UK · b. 1968

Financials

Income Statement

Currency: ZAR	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Revenue	7.93B	8.79B	9.81B	10.94B	11.84B	13.05B	14.65B	16.40B	20.80B	23.49B	25.67B	25.39B	26.89B	20.53B	22.64B	25.79B	25.10B
Growth (%)	-	+10.80%	+11.67%	+11.47%	+8.28%	+10.16%	+12.27%	+12.00%	+26.78%	+12.94%	+9.30%	-1.11%	+5.90%	-23.65%	+10.30%	+13.91%	-2.66%
Cost of Revenue	2.23B	2.43B	2.62B	7.47B	7.58B	3.83B	4.28B	4.76B	5.92B	6.88B	7.53B	7.73B	8.54B	8.96B	17.19B	18.04B	7.92B
Gross Profit	5.70B	6.36B	7.19B	3.46B	4.27B	9.21B	10.37B	11.65B	14.88B	16.61B	18.15B	17.66B	18.35B	5.87B	5.45B	7.75B	17.19B
Gross Margin	71.92%	72.34%	73.28%	31.67%	36.02%	70.63%	70.81%	70.99%	71.56%	70.70%	70.69%	69.55%	68.24%	28.61%	24.06%	30.06%	68.46%
Operating Expense	4.15B	4.49B	5.02B	922.00M	1.32B	5.12B	6.87B	7.99B	11.26B	12.76B	14.20B	15.48B	15.34B	3.11B	3.01B	4.85B	17.70B
Operating Income	1.55B	1.87B	2.17B	2.54B	2.95B	4.09B	3.50B	3.66B	3.62B	3.85B	3.94B	2.18B	3.01B	2.76B	2.44B	2.90B	-508.00M
Operating Margin	19.61%	21.25%	22.14%	23.24%	24.89%	31.37%	23.91%	22.31%	17.41%	16.38%	15.36%	8.59%	11.18%	13.46%	10.77%	11.24%	-2.02%
EBITDA	1.99B	2.26B	2.62B	2.62B	3.39B	4.64B	4.12B	4.04B	4.66B	5.58B	6.28B	4.16B	5.06B	3.52B	3.62B	4.13B	1.04B
EBITDA Margin	25.12%	25.75%	26.73%	23.93%	28.62%	35.57%	28.09%	24.66%	22.40%	23.77%	24.44%	16.39%	18.82%	17.14%	15.97%	16.01%	4.13%
Net Income	937.31M	835.21M	1.49B	1.50B	1.76B	2.77B	1.87B	1.62B	814.00M	1.57B	2.57B	38.00M	1.75B	1.53B	264.00M	4.83B	3.86B
Net Income Margin	11.82%	9.51%	15.21%	13.68%	14.87%	21.26%	12.74%	9.85%	3.91%	6.71%	10.01%	0.15%	6.52%	7.46%	1.17%	18.72%	15.39%
Interest Expense	336.64M	342.15M	251.11M	235.00M	226.00M	230.00M	445.00M	512.00M	1.30B	972.00M	932.00M	716.00M	573.00M	358.00M	563.00M	422.00M	345.00M
Interest Expense % of Total Revenue	4.25%	3.89%	2.56%	2.15%	1.91%	1.76%	3.04%	3.12%	6.25%	4.14%	3.63%	2.82%	2.13%	1.74%	2.49%	1.64%	1.37%

Balance Sheet

Currency: ZAR	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Assets	6.89B	7.87B	8.47B	9.26B	9.97B	11.81B	15.94B	17.50B	36.64B	39.14B	37.57B	42.70B	40.78B	42.24B	45.62B	24.34B	25.69B
Total Liabilities	3.96B	4.36B	4.08B	4.38B	4.36B	5.91B	9.49B	10.70B	21.09B	22.94B	20.07B	24.43B	21.61B	22.38B	24.33B	10.83B	13.55B
Total Equity	2.32B	2.85B	3.52B	3.94B	4.53B	4.79B	5.17B	5.49B	14.38B	14.92B	16.19B	17.06B	18.07B	18.75B	20.21B	12.54B	11.38B
Cash	101.42M	482.16M	400.20M	246.00M	300.00M	422.00M	812.00M	604.00M	1.18B	1.49B	1.54B	2.28B	2.67B	2.80B	846.00M	2.46B	3.81B
Total Debt	2.35B	2.47B	2.02B	2.39B	2.34B	2.69B	3.87B	5.26B	10.59B	13.74B	12.36B	16.39B	12.55B	13.69B	13.19B	4.42B	3.95B
Net Debt	2.25B	1.99B	1.62B	2.14B	2.04B	2.26B	3.06B	4.66B	9.41B	12.25B	10.82B	14.12B	9.89B	10.88B	12.34B	1.96B	141.00M

Cash Flow

Currency: ZAR	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Operating Cash Flow	1.40B	1.84B	1.95B	2.29B	2.61B	2.54B	2.94B	3.06B	3.72B	4.44B	4.66B	4.04B	5.14B	4.23B	4.67B	3.72B	4.04B
Investing Cash Flow	-465.46M	-695.53M	-688.20M	-1.27B	-772.00M	-98.00M	-3.22B	-2.05B	-11.88B	-3.36B	1.77B	-1.99B	-1.47B	-2.70B	-2.93B	16.66B	3.87B
Financing Cash Flow	-1.25B	-787.87M	-1.38B	-1.18B	-2.02B	-2.27B	234.00M	-1.68B	9.30B	-826.00M	-6.76B	-2.78B	-1.25B	-1.41B	-2.63B	-19.62B	-6.51B
Capital Expenditure	551.40M	516.55M	599.66M	580.00M	741.00M	962.00M	1.18B	1.01B	1.66B	2.24B	2.06B	1.96B	1.90B	2.35B	1.21B	1.55B	1.81B
Free Cash Flow	850.65M	1.32B	1.35B	2.29B	1.87B	1.57B	1.76B	2.04B	2.07B	2.20B	2.60B	2.08B	3.24B	1.88B	3.46B	2.17B	2.62B
Dividends Paid	258.60M	532.66M	625.14M	1.03B	1.19B	2.45B	1.52B	1.09B	765.00M	758.00M	1.32B	778.00M	587.00M	587.00M	616.00M	9.47B	5.23B
FCF to OCF	60.67%	71.88%	69.18%	100.00%	71.61%	62.07%	59.82%	66.84%	55.53%	49.46%	55.75%	51.40%	63.07%	44.52%	74.03%	58.29%	64.75%
Dividend Paid to FCF	30.40%	40.34%	46.44%	44.94%	63.56%	155.40%	86.46%	53.23%	36.99%	34.52%	50.91%	37.46%	18.10%	31.16%	17.82%	436.50%	199.89%

Earnings

Report Date	Nov 26, 2026
EPS Estimate	-
EPS Actual	-
Surprise	-
Timing	Pre-market

Key Statistics & Ratios

Market Cap16.64B

Enterprise Value20.37B

Trailing P/E12.51

Forward P/E16.98

PEG Ratio74.95

Price / Sales0.65

Price / Book1.48

EPS0.93

Book Value7.91

Revenue (TTM)25.68B

Gross Profit (TTM)7.17B

EBITDA3.65B

Profit Margin26.69%

Operating Margin10.26%

Return on Equity14.29%

Return on Assets7.03%

Shares Outstanding1.43B

Shares Float1.40B

Beta0.08

Dividend Yield4.99%

Dividend Rate0.58

Payout Ratio60.02%

Dividends

20231×

17.00Jun 13, 2023

20222×

25.00Dec 7, 202215.00Jun 14, 2022

20211×

25.00Dec 8, 2021

20192×

53.00Dec 11, 201940.00Jun 19, 2019

20183×

50.00Dec 12, 201838.00Jun 20, 201845.00Jan 3, 2018

20171×

35.00Jun 28, 2017

20162×

85.60Dec 13, 201667.92Jun 10, 2016

20152×

80.01Dec 7, 201563.27Jun 1, 2015

20143×

72.57Dec 1, 201458.62Jun 2, 201493.04Mar 10, 2014

20132×

0.61Dec 2, 201348.13Jun 3, 2013

20122×

55.82Dec 3, 201232.68Jun 4, 2012

20112×

16.75Dec 5, 201110.23May 30, 2011

20101×

26.98Dec 20, 2010

Stock Splits

Mar 29, 2017273:254